These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 23207153

  • 1. [Correlation between epigenetic alterations in the insulin growth factor-II gene and hepatocellular carcinoma].
    Dong ZZ, Yao DF, Wu W, Qiu LW, Yao NH, Yan XD, Yu DD, Chen J.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):593-7. PubMed ID: 23207153
    [Abstract] [Full Text] [Related]

  • 2. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
    Tang SH, Yang DH, Huang W, Zhou HK, Lu XH, Ye G.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4171-7. PubMed ID: 16857788
    [Abstract] [Full Text] [Related]

  • 3. [Hepatitis B virus X protein promotes insulin-like growth factor II gene expression by inducing hypomethylation of the P3 promoter in hepatocellular carcinoma].
    Tang S, Zhang S, Zhang X, Wu S, Li J, Jiang X, Zhou H, Luo Y, Cao M.
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr 15; 22(4):289-94. PubMed ID: 25173229
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of hepatic igf-ii expression and monitored levels of circulating igf-ii mRNA in metastasis of hepatocellular carcinoma.
    Qian J, Yao D, Dong Z, Wu W, Qiu L, Yao N, Li S, Bian Y, Wang Z, Shi G.
    Am J Clin Pathol; 2010 Nov 15; 134(5):799-806. PubMed ID: 20959664
    [Abstract] [Full Text] [Related]

  • 5. [Abnormal expression of insulin-like growth factor-II and intervening of its mRNA transcription in the promotion of HepG2 cell apoptosis].
    Dong ZZ, Yao M, Qian J, Yan XD, Chen J, Yan MJ, Yao NH, Yao DF.
    Zhonghua Yi Xue Za Zhi; 2013 Mar 26; 93(12):892-6. PubMed ID: 23863671
    [Abstract] [Full Text] [Related]

  • 6. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G, Romano M, Calabrò A, Pedone PV, de Sio I, Persico M, Budillon G, Bruni CB, Riccio A, Zarrilli R.
    Hepatology; 1996 Jun 26; 23(6):1304-12. PubMed ID: 8675143
    [Abstract] [Full Text] [Related]

  • 7. Alteration of oncogenic IGF-II gene methylation status associates with hepatocyte malignant transformation.
    Tai BJ, Yao M, Zheng WJ, Shen YC, Wang L, Sun JY, Wu MN, Dong ZZ, Yao DF.
    Hepatobiliary Pancreat Dis Int; 2019 Apr 26; 18(2):158-163. PubMed ID: 30692043
    [Abstract] [Full Text] [Related]

  • 8. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.
    Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
    Tang S, Hu W, Hu J, Wu S, Li J, Luo Y, Cao M, Zhou H, Jiang X.
    Liver Int; 2015 Feb 15; 35(2):608-19. PubMed ID: 24423280
    [Abstract] [Full Text] [Related]

  • 10. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH, Park IY, Lee JJ, Yang SJ, Jang YJ, Park KC, Kim DJ, Lee DC, Sohn HA, Kim TW, Yoo HS, Choi JY, Bae YS, Yeom YI.
    Gastroenterology; 2010 May 15; 138(5):1898-908. PubMed ID: 20038433
    [Abstract] [Full Text] [Related]

  • 11. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].
    Gu DH, Zhu YZ, Wang X, Bai ZC, Ping JL, Chen Q, Zhu R.
    Zhonghua Zhong Liu Za Zhi; 2013 Apr 15; 35(4):282-7. PubMed ID: 23985257
    [Abstract] [Full Text] [Related]

  • 12. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.
    Dong ZZ, Yao DF, Yao DB, Wu XH, Wu W, Qiu LW, Jiang DR, Zhu JH, Meng XY.
    World J Gastroenterol; 2005 Aug 14; 11(30):4655-60. PubMed ID: 16094705
    [Abstract] [Full Text] [Related]

  • 13. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y, Chen X, Peng S, Fang H, Wu Y, Peng C, Shi L, Bai M, Xu B, Wang J, Deng G.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 25; 82(22):1553-6. PubMed ID: 12609066
    [Abstract] [Full Text] [Related]

  • 14. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K.
    Oncogene; 2000 Nov 02; 19(46):5298-302. PubMed ID: 11077447
    [Abstract] [Full Text] [Related]

  • 15. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D, Kanda M, Nomoto S, Oya H, Takami H, Hibino S, Suenaga M, Inokawa Y, Hishida M, Takano N, Nishikawa Y, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y.
    Oncol Rep; 2014 Mar 02; 31(3):1305-13. PubMed ID: 24366000
    [Abstract] [Full Text] [Related]

  • 16. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ, Wang L, Wang JP, Li JQ, Zhang CQ, Zheng L, Yuan YF.
    Ai Zheng; 2006 Jun 02; 25(6):696-700. PubMed ID: 16764763
    [Abstract] [Full Text] [Related]

  • 17. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I, Pinyol R, Dauch D, Torrecilla S, Tovar V, Moeini A, Alsinet C, Portela A, Rodriguez-Carunchio L, Solé M, Lujambio A, Villanueva A, Thung S, Esteller M, Zender L, Llovet JM.
    Gastroenterology; 2016 Dec 02; 151(6):1192-1205. PubMed ID: 27614046
    [Abstract] [Full Text] [Related]

  • 18. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G.
    Gastroenterology; 2008 Dec 02; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma.
    Cho S, Lee JH, Cho SB, Yoon KW, Park SY, Lee WS, Park CH, Joo YE, Kim HS, Choi SK, Rew JS.
    Pathol Int; 2010 Mar 02; 60(3):203-11. PubMed ID: 20403046
    [Abstract] [Full Text] [Related]

  • 20. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.
    Ann Surg Oncol; 2010 Mar 02; 17(3):923-32. PubMed ID: 19898900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.